» Articles » PMID: 20334534

Effects of Repeated Administrations of Tafluprost, Latanoprost, and Travoprost on Optic Nerve Head Blood Flow in Conscious Normal Rabbits

Overview
Date 2010 Mar 26
PMID 20334534
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The aim of this study was to evaluate and compare the effects of repeated administrations of three prostaglandin F(2alpha) analogs (tafluprost, latanoprost, and travoprost) on optic nerve head (ONH) blood flow in normal rabbits.

Methods: Male Dutch rabbits were housed under a 12-h light-dark cycle for use in this study. A quantitative index of blood flow, the squared blur rate (SBR), was determined using laser speckle flowgraphy. Saline, 0.0015% tafluprost, 0.005% latanoprost, or 0.004% travoprost (each 50 microL) was topically administered into the left eye once daily for 28 days. ONH blood flow was measured before the start at the course of treatment (baseline), and on day 14 and/or day 28 [measurements being made at 0, 30, and/or 60 min after drugs application on day 14 and/or day 28]. Heart rate was also measured at these time points.

Results: Tafluprost, latanoprost, and travoprost each increased the ONH blood flow at all measurement points on day 14 and/or day 28. The 0 min SBR value on day 14 was greater than the baseline SBR value by 8.7% + or - 4.4% for tafluprost and by 5.8% + or - 1.7% for latanoprost. The 0 min SBR value on day 28 was greater than the baseline SBR value by 11.9% + or - 3.9% for tafluprost, by 7.2% + or - 4.3% for latanoprost, and by 6.7% + or - 3.5% for travoprost. The increasing state of the ONH blood flow continued within 60 min after a topical administration of tafluprost, latanoprost, or travoprost. Tafluprost, latanoprost, and travoprost did not change heart rate (vs. the baseline value) at any measurement points.

Conclusions: Repeated topical administration of any of the three prostaglandin F(2alpha) analogs increased ONH blood flow in rabbits, without changing heart rate. The increase in ONH blood flow induced by tafluprost was greater than that induced by latanoprost (P = 0.086) or travoprost (P = 0.037) at 60 min on day 28.

Citing Articles

Nanocarriers for the Delivery of Neuroprotective Agents in the Treatment of Ocular Neurodegenerative Diseases.

Patel C, Pande S, Sagathia V, Ranch K, Beladiya J, Boddu S Pharmaceutics. 2023; 15(3).

PMID: 36986699 PMC: 10052766. DOI: 10.3390/pharmaceutics15030837.


The evaluation of the effect of tafluprost on the intraocular pressure of healthy male guinea pigs under different light-and-darkness regimes.

Armin A, Arfaee F, Ozmaie S, Asghari A Vet Med Sci. 2023; 9(3):1172-1178.

PMID: 36757117 PMC: 10188098. DOI: 10.1002/vms3.1082.


Effects of Tafluprost on Ocular Blood Flow.

Zhang X, Zhou X, Zhao Y, Yang X, Zhou D, Chen B Ophthalmol Ther. 2022; 11(6):1991-2003.

PMID: 36109465 PMC: 9587142. DOI: 10.1007/s40123-022-00566-z.


Neuroaxonal and cellular damage/protection by prostanoid receptor ligands, fatty acid derivatives and associated enzyme inhibitors.

Sharif N Neural Regen Res. 2022; 18(1):5-17.

PMID: 35799502 PMC: 9241399. DOI: 10.4103/1673-5374.343887.


Pulse Waveform Analysis of the Ocular Blood Flow Using Laser Speckle Flowgraphy before and after Glaucoma Treatment.

Masai S, Ishida K, Anraku A, Takumi T, Tomita G J Ophthalmol. 2019; 2019:1980493.

PMID: 31687195 PMC: 6794986. DOI: 10.1155/2019/1980493.